Dear readers,
We are glad to announce of our new website, There you will continue to have access to the full content of the Sharecast newswire, alongside an improved and expanded suite of market data and research tools for both the UK and the main international markets. As a first step in the transition to the new site, over coming days and weeks the news and data pages on will redirect you towards the new website which we earnestly hope you will find even more useful than the current service. Should anyone like to comment or provide constructive criticism on the new layout or what features they would like to see added or deleted, do please send us an e-mail to Lastly, of course, we wish to express our heartfelt gratitude for your support and encouragement over the years as we continued to grow and expand the service.
Very best,


Amphion Innovations jumps on back of Kromek AIM float

Company News

Amphion Innovations jumps on back of Kromek AIM float

Thu, 12 September 2013
Article viewed 201 times
Amphion Innovations jumps on back of Kromek AIM float

A proposed London flotation for one of its investments invigorated shares in private equity incubator Amphion Investments.

Amphion, which invests in small medical and technology companies with promising intellectual property, jumped on the news that Durham University spin-out Kromek intends to float on the AIM section of the London Stock Exchange.

Prior to the placing, Amphion holds a 13.3% equity stake in Kromek, which has developed an x-ray imaging technology that can be used by doctors to detect cancers and osteoporosis and by airport security to detect liquid explosives.

With the help of broker Panmure Gordon, Kromek is looking to raise £15m to accelerate its growth and “harvest value” from its technology.

Richard Morgan, who is Chief Executive Officer of Amphion and Chairman of Kromek, said: "Amphion was the first institutional investor to commit to Kromek in 2005, soon after its formation and spin-out from the University of Durham.

“Since then, we have been closely involved with its development and are delighted to see it is making the transition to a public company.”

Amphion stressed its belief in Kromek’s “substantial” growth opportunities and said floating on the public markets should provide the capital needed to accelerate its growth.

Shares in AMP were up 26% to 3p at 14:21 on Thursday.